7Baggers
 alnylam at jefferies london: strategic momentum and future goals by investing.com  Investing.com Canada Wed, 19 Nov 2025 13:21:12 GMT
 is alnylam pharmaceuticals inc. stock a defensive play in 2025  newser.com Tue, 18 Nov 2025 21:46:07 GMT
 Alnylam, MongoDB, Quanta Services, 11 Others Join IBD Watchlists  Investor's Business Daily Mon, 17 Nov 2025 23:28:00 GMT
 Published on: 2025-11-17 12:11:12  newser.com Mon, 17 Nov 2025 18:11:12 GMT
 new study tests nucresiran’s potential to slow nerve damage  FAP News Today Mon, 17 Nov 2025 16:36:11 GMT
 Published on: 2025-11-15 21:43:46  newser.com Sun, 16 Nov 2025 03:43:46 GMT
 How Alnylam Pharmaceuticals Inc. (ALNY) Affects Rotational Strategy Timing  news.stocktradersdaily.com Sat, 15 Nov 2025 16:38:02 GMT
 Published on: 2025-11-14 20:37:42  newser.com Sat, 15 Nov 2025 02:37:42 GMT
 published on: 2025-11-14 18:28:51  newser.com Sat, 15 Nov 2025 00:28:51 GMT
 published on: 2025-11-13 01:17:44  newser.com Thu, 13 Nov 2025 07:17:44 GMT
 wells fargo raises price target for alnylam pharmaceuticals (aln  GuruFocus Tue, 11 Nov 2025 15:52:45 GMT
 alnylam at ubs healthcare: strategic insights on growth and innovation  Investing.com Mon, 10 Nov 2025 17:50:01 GMT
 alnylam (alny) reports positive results from helios-b phase 3 st  GuruFocus Sun, 09 Nov 2025 17:45:01 GMT
 Alnylam Pharmaceuticals Scores Relative Strength Rating Upgrade  Investor's Business Daily Fri, 07 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 21:04:23  newser.com Thu, 06 Nov 2025 03:04:23 GMT
 published on: 2025-11-05 12:16:44  newser.com Wed, 05 Nov 2025 18:16:44 GMT
 why are pharma companies betting on sirna therapies?  Drug Discovery News Wed, 05 Nov 2025 14:06:57 GMT
 alnylam pharmaceuticals, inc. $alny shares sold by burney co.  MarketBeat Wed, 05 Nov 2025 11:51:14 GMT
 alnylam pharma (alny) receives a rating update from a top analyst  The Globe and Mail Wed, 05 Nov 2025 11:46:39 GMT
 top 20 biopharma companies q3 2025 market cap up 4% despite headwinds  Yahoo Finance Tue, 04 Nov 2025 16:28:03 GMT
 (alny) and the role of price-sensitive allocations  news.stocktradersdaily.com Tue, 04 Nov 2025 15:22:02 GMT

Alnylam Pharmaceuticals, Inc
(NASDAQ:ALNY) 

ALNY stock logo

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, an...

Founded: 2002
Full Time Employees: 1,323
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends